Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-29

Clinical Trial Update: N-3 Polyunsaturated Fatty Acids in the Prevention and Treatment for IFN-induced Depression [NA]

View source ↗

Summary

A completed trial evaluated omega-3 fatty acids for prevention and treatment of interferon-induced depression in individuals with major depressive episodes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: National Science and Technology Council, Taiwan | Conditions: Major Depressive Episode | NA | Status: COMPLETED